Gene · 9049
Papers3,088
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
861 to 880 of 3,088
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Empagliflozin Inhibits Cardiac Late Sodium Current by Ca/Calmodulin-Dependent Kinase II. | Circulation | 2022 | 36251785 | PubTator, text mining | PubMed |
| Using EMDR to treat intimate partner relationship break-up issues. | Front Psychol | 2022 | 36248565 | PubTator, text mining | PubMed |
| Exfoliation of MoS2 Quantum Dots: Recent Progress and Challenges. | Nanomaterials (Basel) | 2022 | 36234593 | PubTator, text mining | PubMed |
| Interfacial Coupling and Modulation of van der Waals Heterostructures for Nanodevices. | Nanomaterials (Basel) | 2022 | 36234543 | PubTator, text mining | PubMed |
| Label-Free Direct Mass Spectrometry Analysis of the Bystander Effects Induced in Chondrocytes by Chondrosarcoma Cells Irradiated with X-rays and Carbon Ions. | Front Biosci (Landmark Ed) | 2022 | 36224025 | PubTator, text mining | PubMed |
| Nanofluidic devices for the separation of biomolecules. | J Chromatogr A | 2022 | 36223665 | PubTator, text mining | PubMed |
| Into the Unknown: How Computation Can Help Explore Uncharted Material Space. | J Am Chem Soc | 2022 | 36206484 | PubTator, text mining | PubMed |
| Vertically Integrated Electronics: New Opportunities from Emerging Materials and Devices. | Nanomicro Lett | 2022 | 36205848 | PubTator, text mining | PubMed |
| Association of Pathology Markers with Somatostatin Analogue Responsiveness in Acromegaly. | Int J Endocrinol | 2022 | 36199813 | PubTator, text mining | PubMed |
| Meta-connectomic analysis maps consistent, reproducible, and transcriptionally relevant functional connectome hubs in the human brain. | Commun Biol | 2022 | 36195744 | PubTator, text mining | PubMed |
| Clinical, hormonal and pathomorphological markers of somatotroph pituitary neuroendocrine tumors predicting the treatment outcome in acromegaly. | Front Endocrinol (Lausanne) | 2022 | 36187106 | PubTator, text mining | PubMed |
| Peptides derived from hookworm anti-inflammatory proteins suppress inducible colitis in mice and inflammatory cytokine production by human cells. | Front Med (Lausanne) | 2022 | 36186812 | PubTator, text mining | PubMed |
| Inhibition of the pseudokinase MLKL alters extracellular vesicle release and reduces tumor growth in glioblastoma. | iScience | 2022 | 36185361 | PubTator, text mining | PubMed |
Feasibility and acceptability of incorporating social network visualizations into a culturally centered motivational network intervention to prevent substance use among urban Native American emerging adults: a qualitative study. | Addict Sci Clin Pract | 2022 | 36180896 | PubTator, text mining | PubMed |
| Optical emissivity dataset of multi-material heterogeneous designs generated with automated figure extraction. | Sci Data | 2022 | 36175557 | PubTator, text mining | PubMed |
| The prevalence of acromegaly is higher than previously reported: Changes over a three-decade period. | Clin Endocrinol (Oxf) | 2022 | 36163677 | PubTator, text mining | PubMed |
| Epigenomic and somatic mutations of pituitary tumors with clinical and pathological correlations in 111 patients. | Clin Endocrinol (Oxf) | 2022 | 36161330 | PubTator, text mining | PubMed |
| Tryptophan metabolism: Mechanism-oriented therapy for neurological and psychiatric disorders. | Front Immunol | 2022 | 36159806 | PubTator, text mining | PubMed |
| Genome wide analysis of circulating miRNAs in growth hormone secreting pituitary neuroendocrine tumor patients' plasma. | Front Oncol | 2022 | 36158656 | PubTator, text mining | PubMed |
| Pituitary carcinoma - case series and review of the literature. | Front Endocrinol (Lausanne) | 2022 | 36157469 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9049/papers?page=44